Annual Midwest Regional ASCO Review 2021
Playback speed
10 seconds
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: Amivantamab & Lazertinib Data
By
Annual Midwest Regional ASCO Review 2021
FEATURING
Patrick Forde
By
Annual Midwest Regional ASCO Review 2021
FEATURING
Patrick Forde
272 views
July 19, 2021
Comments 0
Login to view comments.
Click here to Login
Videos